Filing Details
- Accession Number:
- 0001193805-18-000820
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-11 07:09:38
- Reporting Period:
- 2018-06-08
- Accepted Time:
- 2018-06-11 07:09:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1368514 | Adma Biologics Inc. | ADMA | Biological Products, (No Disgnostic Substances) (2836) | 562590442 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1542517 | S Adam Grossman | C/O Adma Biologics, Inc. 465 State Route 17 Ramsey NJ 07446 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-08 | 20,921 | $4.78 | 32,527 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-06-08 | 52,301 | $4.78 | 796,301 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | See Footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 580,957 | Indirect | See Footnote |
Footnotes
- Represents a purchase from the underwriters in the Issuer's public offering.
- These shares are owned by Areth, LLC ("Areth"). The reporting person is a control person of Areth.
- These shares are owned by Hariden, LLC ("Hariden"). The reporting person is the managing member of Hariden.
Billionaire Hedge Funds
